Utility of Measuring (1,3)-β-d-Glucan in Cerebrospinal Fluid for Diagnosis of Fungal Central Nervous System Infection: TABLE 1

(1-3)- -D-Glucan in Cerebrospinal Fluid Is Useful for the Diagnosis of Central Nervous System Fungal Infections

(2013) M. Mikulska et al.   CLINICAL INFECTIOUS DISEASES

Utility of (1–3)-β-d-Glucan Testing for Diagnostics and Monitoring Response to Treatment During the Multistate Outbreak of Fungal Meningitis and Other Infections

(2013) Anastasia P. Litvintseva et al.   CLINICAL INFECTIOUS DISEASES

Cerebrospinal Fluid (1,3)- -D-Glucan Detection as an Aid for Diagnosis of Iatrogenic Fungal Meningitis

(2013) J. L. Lyons et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cerebrospinal Fluid and Plasma (1->3)- -D-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental Hematogenous Candida Meningoencephalitis

(2008) R. Petraitiene et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reappraisal of the Serum (1→3)‐β‐D‐Glucan Assay for the Diagnosis of Invasive Fungal Infections—A Study Based on Autopsy Cases from 6 Years

(2008) Taminori Obayashi et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES